Texas Lawyers Blog


The Texas Lawyers Blog provides useful information on the law and Texas lawyers. For more information on this Blog or a legal topic, please feel free to submit an inquiry or send an e-mail message to blog@texaslawyers.com

Sunday, September 22, 2013

Byetta Thyroid Cancer Alert: Recent Studies Have Connected Byetta To An Increased Risk of Thyroid Cancer by Byetta Thyroid Cancer Lawyer

Byetta Thyroid Cancer Alert and Byetta Pancreatic Cancer Alert: Recent Scientific Studies Have Connected Byetta To An Increased Risk of Thyroid Cancer and Pancreatic Cancer by Byetta Thyroid Cancer Lawyer and Byetta Pancreatic Cancer Lawyer Jason S. Coomer

Persons taking the injectable diabetes drug, Byetta (Exenatide), should be aware that this diabetes drug may cause an increased risk of thyroid cancer as well as pancreatic cancer.  It is important for any person taking the drug, Byetta, to communicate with their physician to determine the best course of treatment for their diabetes and to make sure that they are aware of any potential cancer symptoms if they continue to take the drug.

If you are taking Byetta and have been diagnosed with thyroid cancer or pancreatic cancer, please feel free to contact Byetta Thyroid Cancer Lawyer and Byetta Pancreatic Cancer Lawyer, Jason S. Coomer about a potential lawsuit. 

Byetta (Exenatide) Has Been Used By Millions of People 

Byetta was the first glucagon-like peptide-1 (GLP-1) receptor agonist to be approved by the FDA for the treatment of type 2 diabetes. Byetta exhibits many of the same effects as the human incretin hormone GLP-1. GLP-1 improves blood sugar after food intake through multiple effects that work in concert on the stomach, liver, pancreas and brain.  Byetta was approved in the U.S. in April 2005 and in Europe in November 2006 and has been used by more than 1.8 million patients since its introduction. Nearly 7 million prescriptions for Byetta were dispensed between April 2005 and September 2008.  In 2010 Byetta sales were over $500 million.  

The Diabetes Drug Market is Over $40 Billion Each Year and Growing Rapidly Byetta had Annual Sale of Over $500 Million in 2010

More than 300 million people worldwide suffer from diabetes and this number is increasing each year.  This number includes about 26 million Americans who are diabetics.  The global market for products in the management of diabetes currently stands at $41 billion and is on pace to grow to over $114 billion by 2018.

With this huge market for diabetic drugs, many drug producers are pushing drugs with known dangers and are attempting to hide the potential dangers of their drugs to keep or obtain a higher market share.  As such, it is important that persons that have developed cancer from specific drugs or families that have lost loved ones from specific drugs step forward and report dangerous drugs to the FDA as well as file lawsuits to make selling dangerous less profitable.

For more information on potentially dangerous drugs, please go to the following web pages: Byetta Pancreatic Cancer Lawsuits and Byetta Thyroid Cancer Lawsuits and Diabetic Drug Pancreatic Cancer Lawsuits.

No comments: